Form 4: Nancy DiMattia, SKYX Platforms Corp. Director, Reports Acquisition of Stock Options and Restricted Stock
SEC Form 4
Director Nancy DiMattia reports acquisition of 26,500 stock options and 26,500 shares of restricted stock in SKYX Platforms Corp.
Summary
- On April 4, 2024, Nancy DiMattia, a director of SKYX Platforms Corp., reported acquiring 26,500 shares of common stock with no par value.
- These shares were acquired as restricted stock that vested immediately upon grant.
- DiMattia also acquired 26,500 stock options with an exercise price of $1.09, vesting monthly from April 30, 2024, and expiring on April 4, 2029.
- The options were granted pursuant to the non-employee director compensation program.
- Following these transactions, DiMattia directly owns 84,770 shares of common stock, 26,500 stock options exercisable at $1.09, 8,000 stock options exercisable at $12.34, and 26,500 stock options exercisable at $3.28.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock and option grants to a director, which is neither particularly positive nor negative.
Positives
- The acquisition of stock and options by a director signals confidence in the company's future performance.
Industry Context
Director ownership changes are routinely monitored by investors as they can provide insights into management's confidence in the company's prospects. Grants of stock options and restricted stock are common components of director compensation packages.
Comparison to Industry Standards
- Director compensation packages, including stock options and restricted stock, are standard practice across publicly traded companies.
- The specific amounts and vesting schedules vary based on company size, industry, and individual contributions.
- Comparing SKYX Platforms Corp.'s director compensation to similar-sized technology companies would provide a benchmark for assessing its competitiveness.
Stakeholder Impact
- The acquisition of shares and options by a director can positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/31/2022 | Date of grant for stock options exercisable at $12.34 |
| 04/30/2023 | Date of grant for stock options exercisable at $3.28 |
| 04/04/2024 | Date of transaction: Acquisition of restricted stock and stock options |
| 04/05/2024 | Date of Form 4 filing |
| 04/30/2024 | Start date for monthly vesting of $1.09 stock options |
| 03/11/2027 | Expiration date for stock options exercisable at $12.34 |
| 04/05/2028 | Expiration date for stock options exercisable at $3.28 |
| 04/04/2029 | Expiration date for stock options exercisable at $1.09 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.